At the same time, the ability of insulin to suppress glucose and VLDL production in the fatty liver is impaired, resulting in mild hyperglycemia and stimulation of insulin secretion, hyper-triglyceridaemia, and low HDL cholesterol concentration, which are also components of MetS. This evidence concerns the gene INS and metabolic syndrome.